Home Delivery Service - Pulmonary Hypertension Drugs - National

NHS England is in the planning stage for a national tender titled "Home Delivery Service - Pulmonary Hypertension Drugs," under the services category. Located in London, this procurement process is part of the NHS National Framework Agreement, aiming to cater to home medical treatment services across the UK. The total estimated value of the tender is £6,000,000 (gross value £7,200,000) in GBP, and it is aimed specifically at small and medium enterprises (SMEs).

The contract is planned to commence on 1st June 2026 and run through to 31st May 2028, with a possible extension till 31st May 2030. Key dates include a future notice expected by 1st January 2026, and further details can be accessed on the NHS England website. This tender presents a significant opportunity for SMEs specializing in home delivery medical services, particularly those with experience in handling pulmonary hypertension medications.

It offers a chance for businesses to engage with a central government authority and secure a sizeable contractual value over a planned period. Companies with expertise in efficient logistics, pharmaceutical handling, and patient-centered care solutions are well-suited to compete and potentially expand their market presence within the healthcare sector through this national framework agreement.